Rifaximin is an antibiotic used for the treatment of intestinal disorders owing to its good luminal antibacterial activity [1]. Modern approaches for the treatment of intestinal diseases are aimed at both a reduction in pathogenic bacteria as well as immune modulation to achieve the most durable remission of disease. Probiotic bacteria exert positive effects on enteric diseases, often working through enhancement of the immune system [2,3]. Rifaximin resistance occurs spontaneously in colonic bifidobacteria during antibiotic treatment [4]. Recently, molecular and phenotypic traits of resistant Bifidobacterium mutants have been described [5,6].

Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis

VITALI, BEATRICE;PERNA, FEDERICO;TURRONI, SILVIA;GIONCHETTI, PAOLO;BRIGIDI, PATRIZIA
2009

Abstract

Rifaximin is an antibiotic used for the treatment of intestinal disorders owing to its good luminal antibacterial activity [1]. Modern approaches for the treatment of intestinal diseases are aimed at both a reduction in pathogenic bacteria as well as immune modulation to achieve the most durable remission of disease. Probiotic bacteria exert positive effects on enteric diseases, often working through enhancement of the immune system [2,3]. Rifaximin resistance occurs spontaneously in colonic bifidobacteria during antibiotic treatment [4]. Recently, molecular and phenotypic traits of resistant Bifidobacterium mutants have been described [5,6].
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
B. Vitali; F. Perna; K. Lammers; S. Turroni; P. Gionchetti; P. Brigidi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/75494
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact